Bhi Back Tablet
FDA Label NDC 62795-1007

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Medinatura Inc for the product Bhi Back (NDC 62795-1007). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, inactive ingredient, purpose, uses, directions, warnings, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient

Each tablet contains: Ammonium muriaticum 6X, *Chamomilla 10X, *Colocynthis 5X, *Gelsemium sempervirens 6X, *Gnaphalium polycephalum 5X, *Rhus toxicodendron 8X 50 mg each.

*Natural Ingredients

Inactive Ingredient

Lactose, Magnesium stearate

Purpose

Back Pain Relief Tablets

Relieves:

• Back Pain

• Leg & Hip Pain

• Muscle Spasm

Uses

For the temporary relief of minor back pain, leg & hip pain, muscle spasm

Directions

At first sign of symptoms:

Adults and children 12 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours.

Standard dosage:

Adults and children 12 years and older: 3 tablets per day, taking 1 tablet every 4 to 6 hours. For children under 12, consult your health professional.

Allow tablets to dissolve completely in the mouth, do not swallow.

Warnings

Warnings: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If symptoms persist or worsen, a health professional should be consulted. Do not use if known sensitivity to BHI Back or any of its ingredients exists.

Keep Out Of Reach Of Children

Keep out of reach of children.

* Please review the disclaimer below.